CTRI/2019/05/018877尚未招募未知
A randomised double blinded comparative study of Fascia Illica Compartment Block and PENG Block for analgesic effect during positioning for spinal anaesthesia in patients with intertrochanteric fracture
Dr Ashok Jadon0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with intertrochanteric fracture of femur scheduled for internal fixation under spinal anaesthesia.
排除标准
- •Patient refusal at any time during study.
- •Contraindication to regional block.
- •Recent surgery on hip or spine with in 3 months.
- •Resting pain is less than 4 on NRS (0-10).
- •Operation is more then 2.5 hrs duration.
- •History of chronic pain and patient is on regular opioids.
研究者
相似试验
已完成
不适用
Comparison of four Fixed Dose Combinations versus standard treatment with separate anti-TB drugs for treatment of pulmonary tuberculosisInfections and InfestationsTuberculosisISRCTN95204603DP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR)1,000
尚未招募
4 期
Comparing prophylactic noradrenaline infusion and phenylephrine infusion after preloading with iv fluids for prevention of fall in blood pressure in elderly patients undergoing proximal femoral nailinig under spinal anaesthesia.CTRI/2024/03/064165Dr Tharigonda Balaji
进行中（未招募）
1 期
A randomised, double-blinded comparison of the effectiveness of intravenously administered Ketoralac versus Dexamethasone in the treatment of pain following surgical removal of third molar teeth under intravenous sedation and local anaesthesia – a pilot study. - North Bristol Oral surgery Intravenous Sedation StudyEUCTR2005-000200-14-GBorth Bristol NHS Trust30
尚未招募
Unknown
To compare the hemodynamic parameters like pulse rate, blood pressure and oxygen saturation efficacy of injection etomidate and propofol during endotracheal intubation.CTRI/2023/07/055797Dr Amrutha H A
进行中（未招募）
1 期
A double blind comparative and randomised study in healthy adults of the safety, tolerability, and immunogenicity of PNEUMOVAX®II formulated with either all new process polysaccharides or all current process polysaccharidesPrevention of invasive pneumococcal disease (IPD)EUCTR2005-002789-12-GBSanofi Pasteur MSD S.N.C